3.59
前日終値:
$3.74
開ける:
$3.6
24時間の取引高:
16,012
Relative Volume:
0.07
時価総額:
$85.98M
収益:
$48.20M
当期純損益:
$-35.05M
株価収益率:
-2.2906
EPS:
-1.5673
ネットキャッシュフロー:
$-13.02M
1週間 パフォーマンス:
+67.76%
1か月 パフォーマンス:
+78.61%
6か月 パフォーマンス:
+56.09%
1年 パフォーマンス:
+21.69%
Celularity Inc Stock (CELU) Company Profile
CELU を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
CELU
Celularity Inc
|
3.59 | 89.57M | 48.20M | -35.05M | -13.02M | -1.5673 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2023-01-30 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
2022-12-22 | ダウングレード | Oppenheimer | Outperform → Perform |
2022-06-22 | 開始されました | H.C. Wainwright | Buy |
2022-04-06 | ダウングレード | Truist | Buy → Hold |
2022-01-28 | 開始されました | Oppenheimer | Outperform |
2021-11-24 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Celularity Inc (CELU) 最新ニュース
What drives Celularity Inc. stock priceTriple-digit return opportunities - Autocar Professional
Is Celularity Inc. a good long term investmentExponential wealth increase - Autocar Professional
What drives Celularity Inc. Equity Warrant stock priceBreakthrough profits - Autocar Professional
What analysts say about Celularity Inc. stockTriple-digit wealth increases - Autocar Professional
Is Celularity Inc. Equity Warrant a good long term investmentOutstanding capital returns - jammulinksnews.com
What analysts say about Celularity Inc. Equity Warrant stockPhenomenal wealth increase - jammulinksnews.com
Celularity Finalizes Private Placement Agreement - TipRanks
Celularity Soared 23.8% Intraday, Could This Biotech Breakout Signal a New Bullish Era? - AInvest
Celularity Inc. Equity Warrant Stock Analysis and ForecastOutstanding capital growth - Autocar Professional
Will Celularity Inc. Equity Warrant stock benefit from AI tech trendsCarefully Curated High Return Stocks - Newser
Celularity Stock Surges Over 8% Amid Florida Stem Cell Policy, New Partnership Boost - AInvest
Why Celularity Inc. Equity Warrant stock attracts strong analyst attentionInsider Strategy Insight - beatles.ru
Celularity Inc. Plunges 16.94% Amid Volatile Trading - AInvest
What makes Celularity Inc. stock price move sharplyRapid Gain Targets - Newser
Celularity Stock: Time to Reconsider? - StocksToTrade
Celularity Inc (CELU) Stock: A Year of Market Fluctuations - investchronicle.com
How Celularity Inc. Equity Warrant stock performs during market volatility3x Growth Potential - Newser
How Celularity Inc. stock performs during market volatilitySecure Your Capital Strategy - Newser
What makes Celularity Inc. Equity Warrant stock price move sharplyFree Access to Community with 300% Return - Newser
Why Celularity Inc. stock attracts strong analyst attentionFree Stock Tips Group - Newser
Celularity Inc (CELU) 財務データ
収益
当期純利益
現金流量
EPS
Celularity Inc (CELU) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Hariri Robert J | Chief Executive Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
3,281 |
0 |
21,482 |
Haines John R | Senior Exec Vice President |
Apr 13 '25 |
Option Exercise |
0.00 |
1,641 |
0 |
29,698 |
Beers David C | Chief Financial Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
1,025 |
0 |
18,561 |
Brigido Stephen | Pres., Functional Regeneration |
Feb 17 '25 |
Option Exercise |
0.00 |
10,000 |
0 |
11,641 |
Beers David C | Chief Financial Officer |
Feb 17 '25 |
Option Exercise |
0.00 |
12,500 |
0 |
21,932 |
Haines John R | Senior Exec Vice President |
Feb 17 '25 |
Option Exercise |
0.00 |
20,000 |
0 |
35,092 |
大文字化:
|
ボリューム (24 時間):